Skip to main content

Month: July 2020

Les Thés DAVIDsTEA obtient une ordonnance initiale dans le cadre de la Loi sur les arrangements avec les créanciers des compagnies

MONTRÉAL, 08 juill. 2020 (GLOBE NEWSWIRE) — Les Thés DAVIDsTEA Inc. (Nasdaq: DTEA) (« DAVIDsTEA » ou la « Société »), l’un des premiers marchands de thé en Amérique du Nord, annonce qu’elle a obtenu de la Cour supérieure du Québec une ordonnance initiale dans le cadre de la Loi sur les arrangements avec les créanciers des compagnies (la « LACC ») afin de mettre en œuvre son plan de restructuration annoncé précédemment. L’ordonnance initiale prévoit notamment la nomination de PwC comme contrôleur dans le cadre de la procédure de la LACC. Comme annoncé précédemment, la Société demandera une ordonnance semblable pour sa filiale américaine en propriété exclusive en vertu du chapitre 15 du code des faillites des États-Unis.Une copie de l’ordonnance initiale et des documents connexes sera disponible sur le site www.pwc.com/ca/davidstea....

Continue reading

The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS

Tofersen is an investigational molecule for superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), the second most common genetic form of ALS, a progressive neurodegenerative diseaseFinal Phase 1/2 study results demonstrated proof-of-concept and proof-of-biology of tofersen, which is currently being investigated in the ongoing Phase 3 VALOR studyBiogen is committed to developing therapies that target the genetic cause of ALS and other difficult-to-treat conditionsCAMBRIDGE, Mass., July 08, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that positive results from a Phase 1/2 study of tofersen (BIIB067) for the potential treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS) were published in The New England Journal of Medicine. A mutation in the SOD1 gene is believed to be a...

Continue reading

Knight Therapeutics Announces CVM Approval of the Tender Offer for remaining 48.8% of Grupo Biotoscana

MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) and its wholly owned subsidiary 1178991 CANADA INC. (“Knight” or “Offeror”) today announced that the Brazilian Securities and Exchange Commission (Comissão de Valores Mobiliários) (“CVM”) has approved the Tender Offer process filed by 1178991 CANADA INC. for the acquisition of all outstanding Brazilian Depositary Receipts (“BDRs”) of Biotoscana Investments S.A. (“GBT” or “Company”).The Tender Offer aims at (i) fulfilling Knight’s statutory obligation to conduct a public offer for the acquisition of the outstanding BDRs following the transfer of control (“Tag Along Tender Offer”); and (ii) the voluntary discontinuity of the BDRs program of the Company (“Discontinuity of the BDR Program”). The Tag Along Tender Offer, together with the Discontinuity...

Continue reading

Thérapeutique Knight annonce l’approbation de la CVM pour l’offre publique d’achat pour les 48,8 % restants de Grupo Biotoscana

MONTRÉAL, 08 juill. 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) et sa filiale en propriété exclusive 1178991 CANADA INC. (« Knight » ou « l’offrant ») ont annoncé aujourd’hui que la Comissão de Valores Mobiliários du Brésil (« CVM »), la Securities and Exchange Commission of Brazil, a approuvé l’offre publique d’achat déposée par 1178991 CANADA INC. pour l’acquisition de tous les certificats de dépôt brésiliens (« CDB ») de Biotoscana Investments S.A. (« GBT » ou « la Société ») en circulation.L’offre publique d’achat vise (i) à remplir l’obligation statutaire de Knight de mener une offre publique d’achat pour l’acquisition des CDB en circulation suite au transfert de contrôle (« offre publique d’achat conditionnelle »); et (ii) la cessation volontaire du programme de CDB de la Société (« cessation du programme...

Continue reading

Quinto Resources reconfirms delay in filing its financial statements and MD&A for the year ended January 31, 2020 and the first quarter of 2020 due to COVID-19 related-delays

MONTREAL, July 08, 2020 (GLOBE NEWSWIRE) — Quinto Resources Inc. (TSXV: QIT) (“Quinto” or the “Company”), further to its May 29, 2020 news release, is continuing to rely on temporary relief granted by Canadian securities regulators, allowing reporting issuers to extend certain continuous disclosure filing deadlines by 45 days and reconfirms the delay in the filing of its financial statements and management’s discussion and analysis (“MD&A”) for the year ended January 31, 2020, and for the first quarter ended April 30, 2020, due to logistics and delays caused by the COVID-19 pandemic.The Company still expects to file its audited annual financial statements and accompanying MD&A on or before July 15, 2020, and now expects to file its first quarter financial statements and accompanying MD&A on or before July 31,...

Continue reading

SmartFinancial Sets Second Quarter Earnings Release and Conference Call Dates

KNOXVILLE, Tenn., July 08, 2020 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial”) (NASDAQ:SMBK) announces details for the release of its results for the Second Quarter of 2020.SmartFinancial plans to issue its earnings release for the second quarter of 2020 on Tuesday, July 21, 2020, and will host a conference call on Wednesday, July 22, at 10:00 a.m. ET.  To access this interactive teleconference, dial (888) 317-6003 or (412) 317-6061 and enter the confirmation number, 5925756.  A replay of the conference call will be available through July 22, 2021, by dialing (877) 344-7529 or (412) 317-0088 and entering the confirmation number, 10146072.Conference call materials (earnings release & conference call presentation) will be published on the company’s webpage located at http://www.smartfinancialinc.com/CorporateProfile,...

Continue reading

Dealnet Announces Rebounding Originations

TORONTO, July 08, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) announced today that organic originations of finance receivables for the six months ended June 30, 2020 were $20.5 million, a decline from originations of $25.4 million in Q1 and Q2 2019.  Organic originations of finance receivables for the quarter ended June 30, 2020 were $6.4 million (Q2 2019 – $12.9 million). The originations remain at a similar high credit quality and yield as the prior periods.As announced in Q1 2020, the most significant financial impact of COVID-19 on Dealnet is on its originations from its dealer base.“Business at our dealers is picking up as COVID-19 restrictions across Canada are eased and consumers regain confidence to make major purchasing decisions,” said Brent Houlden, Dealnet’s...

Continue reading

Sensata Technologies to Release Second Quarter 2020 Financial Results on July 28, 2020

SWINDON, United Kingdom, July 08, 2020 (GLOBE NEWSWIRE) — Sensata Technologies (NYSE:ST) today announced that it will disclose its second quarter 2020 financial results on Tuesday, July 28, 2020, at 6:00 a.m. Eastern Time.Sensata will then host a live conference call and webcast on the same day at 8:00 a.m. Eastern Time to discuss the results and business trends. The webcast and subsequent replay will be available on the investor relations page of the Company’s website at http://investors.sensata.com.Investors can also listen to the earnings call live via telephone by dialing 1-844-784-1726 or 1-412-380-7411 and referencing the Sensata Q2 2020 Financial Results Conference Call.  A replay of the call will be available until August 4, 2020.  To access the replay dial 1-877-344-7529 or 1-412-317-0088 and enter confirmation code: 10146020.About...

Continue reading

First Commonwealth to Host Second Quarter 2020 Earnings Conference Call on Wednesday, July 29, 2020

INDIANA, Pa., July 08, 2020 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) announced today that it will host a conference call on Wednesday, July 29, 2020 at 2:00 p.m. Eastern Time to discuss financial results for the quarter ended June 30, 2020.  The call will be hosted by T. Michael Price, President and Chief Executive Officer.  He will be joined by James R. Reske, Executive Vice President and Chief Financial Officer, Jane Grebenc, Executive Vice President and Chief Revenue Officer and Brian G. Karrip, Executive Vice President and Chief Credit Officer.  First Commonwealth will issue a press release reporting its Second Quarter 2020 financial results after the market closes on Tuesday, July 28, 2020.Conference Call InformationTo listen to the conference call, either dial the phone number above or go to...

Continue reading

Canoe EIT Income Fund Announces July 2020 Distribution

CALGARY, Alberta, July 08, 2020 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (the “Fund”) (TSX – EIT.UN) announces the July 2020 distribution of $0.10 per unit.  The distribution will be paid on August 14, 2020 to unitholders of record on July 22, 2020.  The ex-distribution date for this distribution is July 21, 2020.About Canoe EIT Income FundOne of Canada’s largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbol EIT.UN and is actively managed by Robert Taylor, Senior Vice President and Portfolio Manager of Canoe Financial.About Canoe FinancialCanoe Financial is one of Canada’s fastest growing independent mutual fund companies managing over $7.5 billion in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.